| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/08/2012 | CN101953784B 含阿莫西林、硫酸粘菌素和泼尼松龙的兽用混悬液及其制备方法 Containing amoxicillin, colistin sulphate and prednisolone veterinary suspensions and preparation method |
| 02/08/2012 | CN101817871B 迟缓爱德华氏菌密度感应系统阻断因子及其构建和应用 E. tarda density induced blocking factor and build systems and applications |
| 02/08/2012 | CN101810860B 一种有抗肿瘤协同增效作用的药物组合物 A kind of synergistic anti-tumor pharmaceutical composition |
| 02/08/2012 | CN101792485B α型芋螺多肽及其应用 α-type Conus peptides and its application |
| 02/08/2012 | CN101736008B 一种制备基因工程N-乙酰化胸腺素α1的方法 A process for preparing N- acetylated genetic engineering methods thymosin α1 |
| 02/08/2012 | CN101709321B 一种燕麦多肽及其制备方法与应用 One kind of oat peptides and preparation method and application |
| 02/08/2012 | CN101670092B 一种注射用促肝细胞生长素冻干粉针剂的制备方法 An injectable preparation pHGF freeze-dried powder |
| 02/08/2012 | CN101426515B 新的肠球菌和链球菌菌株及细菌素 New strains of enterococci and streptococci and bacteriocins |
| 02/08/2012 | CN101370510B 包含肽的抗癌剂 Peptides containing the anticancer agent |
| 02/08/2012 | CN101186940B 获得具有正确键合的胱氨酸键的胰岛素或胰岛素衍生物的方法 Cystine bonds obtained insulin or insulin derivative having correctly bonded method |
| 02/08/2012 | CN101180082B 利用siv-pedf载体治疗伴随眼组织细胞凋亡变性的疾患的药物 Use siv-pedf vehicle treated apoptotic degeneration associated with ocular tissue disorders drug |
| 02/08/2012 | CN101060854B 具有抗糖尿病作用的蛋白质水解物 Protein hydrolysates have anti-diabetic action |
| 02/07/2012 | US8110668 Sperm-specific cation channel, catsper-3 and uses therefor |
| 02/07/2012 | US8110662 Culture product; hybridization; antibody that binds to purified polypeptide |
| 02/07/2012 | US8110657 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/07/2012 | US8110654 T cell epitope peptides of ovarian cancer anti-idiotypic antibody 6B11 and use thereof |
| 02/07/2012 | US8110653 Collections of repeat proteins comprising repeat modules |
| 02/07/2012 | US8110598 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 02/07/2012 | US8110565 Of the ACE inhibitor ramipril; controlling the melting point by mixing with the free acid with the ramipril ethyl or methyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 02/07/2012 | US8110554 Peptides whose uptake by cells is controllable |
| 02/07/2012 | US8110553 Methods and compositions for the treatment of gastrointestinal disorders |
| 02/07/2012 | US8110552 Antagonists against interaction of PF4 and RANTES |
| 02/07/2012 | US8110551 Cytolethal distending toxin and use thereof |
| 02/07/2012 | US8110550 HDAC inhibitors and hormone targeted drugs for the treatment of cancer |
| 02/07/2012 | US8110549 Alpha-conotoxin peptides |
| 02/07/2012 | US8110548 Method for treating cartilage disorders |
| 02/07/2012 | US8110547 Compositions for buccal delivery of parathyroid hormone |
| 02/07/2012 | US8110546 VEGF antagonist formulations |
| 02/07/2012 | US8110545 Non-proteolysable oligopeptides that inhibit glycoprotein GP41 of the aids virus |
| 02/07/2012 | US8110544 RasGAP derived peptide for selectively killing cancer cells |
| 02/07/2012 | US8110543 Anti-invasive and anti-angiogenic compositions |
| 02/07/2012 | US8110542 Methods of expressing proteins with disulfide bridges |
| 02/07/2012 | US8110399 Isolating nestin-positive stem cells, expanding and translplanting into a patient to replace lost or damaged insulin secreting cells; differentiating pancreatic stem cells to obtain cells that produce insulin and other hormones |
| 02/07/2012 | US8110378 Nucleic acids encoding DCRS5 |
| 02/07/2012 | US8110377 HGF β chain variants |
| 02/07/2012 | US8110367 Methods for diagnosing renal disorders |
| 02/07/2012 | US8110354 Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 02/07/2012 | US8110224 Matrix containing biodegradable polymer, water soluble polymer and drugs; mixture containing water insoluble surfactant such as lecithin or phosphatide |
| 02/07/2012 | US8110218 Compositions and methods for less immunogenic protein-lipid complexes |
| 02/07/2012 | US8110203 Adjuvant comprising non-toxic cross-linked muramyl dipeptide (MDP) microparticles derived from Propionibacterium acnes |
| 02/07/2012 | US8110202 Synthetic vaccine for tick control |
| 02/07/2012 | US8110189 Using monoclonal antibody specific to biliary glycoprotein as tool in treatment and prevention of cell proliferative, autoimmune, immunodeficiency and transplant rejection disorders |
| 02/07/2012 | US8110187 Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto |
| 02/07/2012 | US8110182 Treatment of multiple sclerosis by administration of interferon alpha and C-phycocyanin |
| 02/07/2012 | US8110181 Method of treating tuberculosis with interferons |
| 02/07/2012 | US8110180 Method of use of cytokine ZALPHA11 ligand |
| 02/07/2012 | US8110177 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 02/07/2012 | CA2624175C Cgrp peptide antagonists and conjugates |
| 02/07/2012 | CA2499783C Antibacterial peptide |
| 02/07/2012 | CA2491716C Processes for the preparation of fibrinogen |
| 02/07/2012 | CA2470235C Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof |
| 02/07/2012 | CA2452923C Peptide-based compounds for targeting integrin receptors |
| 02/07/2012 | CA2431669C Pesticidal and antiparasitic compositions comprising chitinase or chitin and sulfide |
| 02/07/2012 | CA2423994C Autologous bone graft material |
| 02/07/2012 | CA2386463C April receptor (bcma) and uses thereof |
| 02/07/2012 | CA2385312C Compositions and methods for preventing and treating transplant rejection |
| 02/07/2012 | CA2383850C Prevention and treatment of mycoplasma-associated diseases |
| 02/07/2012 | CA2382388C Fraction extracted from archaebacteria for cosmetic purposes |
| 02/07/2012 | CA2366785C Soluble tumor necrosis factor receptor treatment of medical disorders |
| 02/07/2012 | CA2340863C Thrombin preparations and process for their production |
| 02/07/2012 | CA2333147C Cancer treatment methods using antibodies to aminophospholipids |
| 02/07/2012 | CA2328989C Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 02/07/2012 | CA2301964C Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 02/07/2012 | CA2264484C Human plasma hyaluronidase |
| 02/07/2012 | CA2225898C Enhancing keratinocyte migration and proliferation |
| 02/02/2012 | WO2012016229A2 Oxytocin treatment to improve memory and modify blood glucose |
| 02/02/2012 | WO2012016186A1 Macrocyclic kinase inhibitors and uses thereof |
| 02/02/2012 | WO2012016162A2 Compositions, methods and kits for modeling, diagnosing, and treating complement disorders |
| 02/02/2012 | WO2012015979A2 Hmgb1-derived peptides enhance immune response to antigens |
| 02/02/2012 | WO2012015975A2 Glp-1 receptor agonist compounds having stabilized regions |
| 02/02/2012 | WO2012015969A1 Compositions and methods for increased delivery of coenzyme q10 |
| 02/02/2012 | WO2012015910A2 Use of adnf polypeptides for treating neurodegenerative diseases |
| 02/02/2012 | WO2012015903A1 Treatment of type i diabetes mellitus (t1dm) in young newly diagnosed patients |
| 02/02/2012 | WO2012015836A1 Highly potent peptides to control cancer and neurodegenerative diseases |
| 02/02/2012 | WO2012015785A1 Method for generating thrombin |
| 02/02/2012 | WO2012015712A1 Inhibition of cyp3a drug metabolism |
| 02/02/2012 | WO2012015662A1 Il-18 receptor as a novel target of regulatory t cells in cancer |
| 02/02/2012 | WO2012015605A1 Polypeptides for use in the deconstruction of cellulose |
| 02/02/2012 | WO2012015325A1 Stabilized immune correction drug viferon-forte for the treatment of infectious inflammatory diseases |
| 02/02/2012 | WO2012015211A2 Opthalmic formulation containing cyclosporine a |
| 02/02/2012 | WO2012015055A1 Collagen powder and/or collagen-derived powder, and production method for same |
| 02/02/2012 | WO2012015037A1 Antimicrobial activity enhancing agent |
| 02/02/2012 | WO2012014901A1 Carbonylation inhibitor |
| 02/02/2012 | WO2012013979A1 Anti-viral agent |
| 02/02/2012 | WO2012013742A2 Stabilization of fsh |
| 02/02/2012 | WO2012013709A1 Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion |
| 02/02/2012 | WO2012013704A1 Particle comprising cytokines, antibodies and polymers and use thereof as medicament for the treatment of cancer |
| 02/02/2012 | WO2012013597A1 Substances and the use thereof for influencing natriuretic peptide receptors |
| 02/02/2012 | WO2012013249A1 Dentin matrix protein 1 (dmp1) for use in pharmaceutical compositions |
| 02/02/2012 | WO2012013111A1 Angiogenesis-inhibiting peptide and application thereof |
| 02/02/2012 | WO2012013110A1 Polypeptide having angiogenesis-inhibiting activity |
| 02/02/2012 | WO2012012870A1 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex |
| 02/02/2012 | WO2012012843A1 Modulators of protease activated receptors |
| 02/02/2012 | WO2011156903A3 Innate defence regulatory peptide compositions for treatment of arthritis |
| 02/02/2012 | WO2011148083A4 Peptide for use as a medicament, in particular for the treatment of cancer |
| 02/02/2012 | WO2011147981A3 Neuregulin isoforms, neuregulin polypeptides and uses thereof |
| 02/02/2012 | WO2011130552A9 Serca2 therapeutic compositions and methods of use |
| 02/02/2012 | WO2011127302A3 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems |
| 02/02/2012 | WO2011118981A3 Novel use of erythroid differentiation regulator 1 as an agent for treating cancer |
| 02/02/2012 | WO2011113019A3 Ctla4 proteins and their uses |